MEMBRANOUS NEPHROPATHY
Clinical trials for MEMBRANOUS NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new MEMBRANOUS NEPHROPATHY trials appear
Sign up with your email to follow new studies for MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cell injection targets Hard-to-Treat kidney diseases
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy called GT719 in about 30 adults with immune-mediated kidney diseases such as IgA nephropathy and membranous nephropathy. The study aims to check the safety of the treatment and find the best dose. Participants receive a single injec…
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
Engineered immune cells take aim at Hard-to-Treat kidney disease
Disease control Not yet recruitingThis early-stage study tests a new treatment for people with severe autoimmune kidney diseases (lupus nephritis, IgA nephropathy, or membranous nephropathy) that have not responded to standard therapies. The treatment uses specially engineered immune cells (CAR-γδ T cells) design…
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: EARLY_PHASE1 • Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Scientists hunt for genetic clues to match kidney patients with best therapy
Knowledge-focused Not yet recruitingThis study looks at stored blood and kidney samples from 120 people with membranous nephropathy (a kidney disease) and healthy volunteers. Researchers want to find genetic and protein markers that can predict which patients will respond well to the drug rituximab. The goal is to …
Matched conditions: MEMBRANOUS NEPHROPATHY
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated May 26, 2026 08:52 UTC